EUCTR2009-012654-20-IT进行中（未招募）不适用
sistemic thrombolysis with Alteplase between 3-4.5 hours in acute ischaemic stroke. Evaluation of clinical efficacy - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2009年5月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- ischaemic stroke between 3-4.5 hours from onset
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- contraindication of thrombolysis
研究者
相似试验
尚未招募
不适用
IV THROMBOLYSIS(rt PA-Alteplase) AS TREATMEANT IN SEVERE COVID ARDSCTRI/2021/08/035445COLUMBIA ASIA REFERRAL HOSITA
撤回
3 期
Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary EmbolismPulmonary EmbolismNCT02604238Azienda U.S.L. 1 di Massa e Carrara
已完成
不适用
Study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurololidine-citrate and heparin catheter locks in patients treated with haemodialysisISRCTN07668752ancashire Teaching Hospitals NHS trust (UK)106
尚未招募
4 期
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling DeficitsNCT06115070Second Affiliated Hospital, School of Medicine, Zhejiang University390
进行中（未招募）
1 期
Comparing three different treatment options for acute clots in the pulmonary vesselsAcute Pulmonary Embolism, intermediate high risk (visible impact on right ventricular structure and function, and biochemical markers og myocardial damage according to the European Society of Cardiology Guidelines)MedDRA version: 21.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2017-005075-91-DKCopenhagen University Hospital Rigshospitalet210